COLTENE N revenue breakdown overview

COLTENE N revenue for the last year amounted to 242.73 M CHF, the most of which — 91.14 M CHF — came from its highest performing source at the moment, Efficient Treatment, the year earlier bringing 100.51 M CHF. The greatest contribution to the revenue figure was made by North America — last year it brought COLTENE N 112.19 M CHF, and the year before that — 128.93 M CHF.